BiotechTube
Home/Corsair Pharma/George W. Mahaffey
GW

George W. Mahaffey

CEO and Director

Corsair Pharma

Therapeutic Areas

Pulmonary Arterial Hypertension (PAH)Pulmonary Hypertension

Corsair Pharma Pipeline

DrugIndicationPhase
Transdermal Treprostinil Prodrug PatchPulmonary Arterial Hypertension (PAH)Pre-clinical

Leadership Team at Corsair Pharma

BS
Bobby Singh, Ph.D.
President, COO and Director
IG
Ivan Gergel, M.D.
Director
NR
Nishant Rastogi
Director
NM
Narasimhan Mani, Ph.D.
Director
FS
Faysal Sohail
Director
PS
Peter Staple
Director
View full Corsair Pharma profile